SEQIRUS for SEQIRUS
Versions of this report
Every filing the register holds for this firm, client and period, oldest first. The most recent one is the version LegiList counts.
| Filing | Filed | Amount | Counted |
|---|---|---|---|
| 3rd Quarter - Report | Oct 20, 2025 | $250,000 | Replaced |
| 3rd Quarter - Amendment (this page) | Feb 19, 2026 | $400,000 | Yes |
What was lobbied
2 issue areas, each in the filer's own words, with who lobbied on it and where.
Budget/Appropriations BUD
FY2025 and FY2026 Appropriations, policies related to pandemic preparedness, public health, and influenza preparedness; H.R. 3838/S. 2296, FY2026 NDAA, policies related to pandemic preparedness, public health, and influenza preparedness;
Foreign entity interest: CSL Limited, identified on Registration (LD-1), is the parent company of Seqirus and benefits from the financial success thereof.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINE FARQUHARSON | — |
Health Issues HCR
FY2025 and FY2026 Appropriations, policies related to pandemic preparedness, public health, and influenza preparedness; H.R. 3838/S. 2296, FY2026 NDAA, policies related to pandemic preparedness, public health, and influenza preparedness;
Foreign entity interest: CSL Limited, identified on Registration (LD-1), is the parent company of Seqirus and benefits from the financial success thereof.
| Lobbyist | Covered position, as disclosed |
|---|---|
| CHRISTINE FARQUHARSON | — |
Shown as published by the Senate Office of Public Records and the House Clerk under the Lobbying Disclosure Act. The official filing is the record; open it for the full form.